653
On 4 September 2006, a new orphan medicinal product was registered into the community register of orphan medicinal products under the EU orphan designation number number 394. The active ingredient is autologous tumor-derived immunoglobulin idiotype coupled to keyhole limpet haemocyanin for treatment of follicular lymphoma.